Quarter Ended Sep 30, 2024
Net sales were up 3% to $114.6 million compared to $111.2 million (up 4% in constant currency).
GAAP net income attributable to common shareholders was $4.3 million, or $0.23 per diluted common share, compared to $2.8 million, or $0.15 per diluted common share.
Adjusted EBITDA was up 5% to $10.7 million compared to $10.3 million.
For complete information regarding our financials, see our periodic filings.